NCT05125822

Brief Summary

In this study, doctors want to find out more about why people who lose weight often regain the weight that they have lost once they resume a regular diet and whether hormones might play a role in weight regain. The study is divided into two parts, called the meal replacement period and the follow-up period. The meal replacement period will consist of drinking a shake for breakfast and lunch and eating a frozen meal for dinner that is calorie controlled. Individuals will also be asked to eat two servings of fruit and three servings of vegetables each day. The study will provide the shakes and the frozen entrees, participants are asked to supply the fruits and vegetables. Participation in this study will last for up to 35 weeks. There will be 10 in-person visits and 13 visits by phone or over Zoom over the 35 weeks.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
260

participants targeted

Target at P75+ for not_applicable

Timeline
20mo left

Started Aug 2023

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress63%
Aug 2023Jan 2028

First Submitted

Initial submission to the registry

November 8, 2021

Completed
10 days until next milestone

First Posted

Study publicly available on registry

November 18, 2021

Completed
1.8 years until next milestone

Study Start

First participant enrolled

August 26, 2023

Completed
2.7 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 1, 2026

Completed
1.7 years until next milestone

Study Completion

Last participant's last visit for all outcomes

January 1, 2028

Expected
Last Updated

August 22, 2024

Status Verified

August 1, 2024

Enrollment Period

2.7 years

First QC Date

November 8, 2021

Last Update Submit

August 20, 2024

Conditions

Outcome Measures

Primary Outcomes (3)

  • Change in fat mass regain after initial weight loss with meal replacement therapy (MRT)

    We hypothesize that the greater the initial weight loss with MRT the greater the fat mass regain at 26 weeks.

    17 weeks.

  • Change in ghrelin

    We hypothesize that after the initial weight loss with MRT that we will see an increase in the level of the appetite regulating hormone ghrelin.

    17 weeks.

  • Change in gastric inhibitory polypeptide

    We hypothesize that after the initial weight loss with MRT that we will see an increase in the level of the appetite regulating hormone gastric inhibitory polypeptide.

    17 weeks

Study Arms (1)

Meal Replacement and Lifestyle Therapy

EXPERIMENTAL

Participants in this study will have an 8-week meal replacement therapy period in which they are asked to reduce their BMI by 5% by following a prescribed eating regimen consisting of meal replacement shakes and/or frozen meals for breakfast and lunch. For dinner they will consume a pre-packaged frozen entree to be consumed with two servings of fruit and three servings of vegetables per day. Participants will also have lifestyle/behavioral modification counseling every 2 weeks throughout the entire study.

Other: Meal replacement and lifestyle modification

Interventions

Meal replacement and lifestyle modification

Meal Replacement and Lifestyle Therapy

Eligibility Criteria

Age11 Years - 15 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17)

You may qualify if:

  • to less than 16 years old
  • BMI \> 30 kg/m\^2 or 95th BMI percentile
  • Tanner stage 2, 3, or 4

You may not qualify if:

  • Tanner stage 1 and 5
  • Prior bariatric surgery
  • Monogenic and hypothalamic obesity
  • Polycystic ovary syndrome (diagnosed by a physician)
  • Pregnancy or planned pregnancy
  • Current use of supplemental hormones
  • Individuals with a diagnosed eating disorder of anorexia nervosa, bulimia or binge eating disorder
  • Type 1 or 2 diabetes
  • Treatment with growth hormones
  • Thyroid disease/problem
  • Has had cancer in the last 10 years

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Ann & Robert H Lurie Children's Hospital of Chicago

Chicago, Illinois, 60611, United States

RECRUITING

MeSH Terms

Conditions

Pediatric Obesity

Condition Hierarchy (Ancestors)

ObesityOverweightOvernutritionNutrition DisordersNutritional and Metabolic DiseasesBody WeightSigns and SymptomsPathological Conditions, Signs and Symptoms

Study Officials

  • Justin Ryder, PhD

    Ann & Robert H Lurie Children's Hospital of Chicago

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Justin Ryder, PhD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
BASIC SCIENCE
Intervention Model
SINGLE GROUP
Model Details: This is a single group study that will consist of two interventions: an 8-week meal replacement therapy period in which participants are asked to reduce their body mass index (BMI) by \>/= 5% by following a prescribed eating regimen and standardized lifestyle/behavior modification counseling which will occur every 2 weeks throughout the study.
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

November 8, 2021

First Posted

November 18, 2021

Study Start

August 26, 2023

Primary Completion

May 1, 2026

Study Completion (Estimated)

January 1, 2028

Last Updated

August 22, 2024

Record last verified: 2024-08

Locations